Facilitated By

San Antonio Medical Foundation

P. berghei complete liver stage compound profiling

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Hanson, Kirsten
Funded by
Medicines for Malaria Venture
Research Start Date

Profiling MMV portfolio compound activity against the complete P. berghei liver stage.Scope includes compound screenings and portfolio compound testing where data will be delivered within 2 weeks of the end of the test run.

Assays will be ran to detect compounds with activity throughout the P. berghei liver stage. Primary screening will be approved by MMV. After triage, all potential actives will be subjected to full phenotypic profiling at UTSA. Phenotypic profiles will be compared against MMV validation set.  

Collaborative Project
Basic Research
Drug Discovery
Infectious Disease